Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions2026-07-010 PRE AI LLillian Seo RRoger Paredes RRami Kantor * DOI:10.1093/infdis/jiag340OriginalOriginal request for helpShareSaveAbstract En